GlycoMimetics (GLYC) Reports In-Line Q3 EPS

GlycoMimetics (NASDAQ: GLYC) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• RH (RH) Tops Q1 EPS by 12c
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital